{
  "document": "Foundation_4",
  "Genomic Findings": [
    {
      "Name": "EGFR exon 19 deletion (E746-A750del)",
      "Clinical": [
        "Afatinib",
        "Dacomitinib",
        "Erlotinib",
        "Gefitinib",
        "Osimertinib"
      ],
      "No Clinical": []
    },
    {
      "Name": "MET amplification - equivocal",
      "Clinical": [
        "Capmatinib",
        "Crizotinib",
        "Erlotinib",
        "Tepotinib",
        "Gefitinib",
        "Osimertinib"
      ],
      "No Clinical": ["Cabozantinib"]
    },
    { "Name": "CCNE1 amplification", "Clinical": [], "No Clinical": [] },
    { "Name": "MYCC amplification", "Clinical": [], "No Clinical": [] },
    { "Name": "RNF4 R145*", "Clinical": [], "No Clinical": [] },
    { "Name": "RAD21 amplification", "Clinical": [], "No Clinical": [] },
    { "Name": "TP53 P15P151T1T", "Clinical": [], "No Clinical": [] },
    { "Name": "ZNF217 amplification", "Clinical": [], "No Clinical": [] }
  ],
  "Biomakers findings": [
    {
      "Name": "Microsatellite status - MS-Stable",
      "Clinical": [],
      "No Clinical": []
    },
    {
      "Name": "Tumor Mutational Burden - 4 Muts/Mb",
      "Clinical": [],
      "No Clinical": []
    }
  ]
}
